H. Hogerzeil

Most-cited papers

1. Field tests for rational drug use in twelve developing countries.

   H. Hogerzeil, D. Ross-Degnan, R. Laing, D. Ofori-Adjei +6 more

   1993The Lancet358 citations

   Semantic Scholar

   Save

2. Ten recommendations to improve use of medicines in developing countries.

   R. Laing, H. Hogerzeil, D. Ross-Degnan

   2001Health Policy and Planning350 citations

   Semantic Scholar

   Save

3. Essential medicines for universal health coverage

   V. Wirtz, H. Hogerzeil, Andrew L Gray, M. Bigdeli +18 more

   2016The Lancet321 citations Open access

   Semantic Scholar

   Save

4. Intervention research in rational use of drugs: a review.

   A. le Grand, H. Hogerzeil, F. Haaijer-Ruskamp

   1999Health Policy and Planning314 citations Open access

   Semantic Scholar

   Save

5. Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts?

   H. Hogerzeil, Melanie Samson, J. Casanovas, Ladan Rahmani-Ocora

   2006The Lancet212 citations

   Semantic Scholar

   Save

6. The selection and use of essential medicines.

   P. Kazembe, J. Al-Fannah, K. Hoppu, E. Zisovska +23 more

   2008World Health Organization technical report series207 citations

   Semantic Scholar

   Save

7. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.

   H. Hogerzeil, J. Liberman, V. Wirtz, S. Kishore +4 more

   2013The Lancet198 citations

   Semantic Scholar

   Save

8. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002.

   Kenneth Chebet, M. Dybul, C. Giaquinto, E. Katabira +11 more

   2002IAPAC monthly159 citations Open access

   Semantic Scholar

   Save

9. The concept of essential medicines: lessons for rich countries

   H. Hogerzeil

   2004British medical journal152 citations Open access

   Semantic Scholar

   Save

10. Twenty-five years of essential medicines.

    J. Quick, H. Hogerzeil, G. Velásquez, L. Rágo

    2002Bulletin of the World Health Organization149 citations

    Semantic Scholar

    Save

11. Essential medicines and human rights: what can they learn from each other?

    H. Hogerzeil

    2006Bulletin of the World Health Organization142 citations Open access

    Semantic Scholar

    Save

12. A quiet revolution in global public health: The World Health Organization’s Prequalification of Medicines Programme

    E. '. 't Hoen, H. Hogerzeil, J. Quick, H. Sillo

    2014Journal of Public Health Policy93 citations

    Semantic Scholar

    Save

13. Selection of Essential Drugs

    H. Hogerzeil

    1986Tropical doctor91 citations

    Semantic Scholar

    Save

14. Prescription habits of dispensing and non-dispensing doctors in Zimbabwe.

    B. Trap, E. Hansen, H. Hogerzeil

    2002Health Policy and Planning83 citations Open access

    Semantic Scholar

    Save

15. THE WORLD MEDICINES SITUATION 2011 ACCESS TO ESSENTIAL MEDICINES AS PART OF THE RIGHT TO HEALTH

    H. Hogerzeil, Z. Mirza

    201168 citations

    Semantic Scholar

    Save

16. The Development of Reference Values for the WHO Health Facility Core Prescribing Indicators

    A. Isah, R. Laing, J. Quick, A. Mabadeje +3 more

    200165 citations

    Semantic Scholar

    Save

17. Stability of essential drugs during shipment to the tropics.

    H. Hogerzeil, A. Battersby, V. Srdanović, N. E. Stjernstrom

    1992British medical journal57 citations Open access

    Semantic Scholar

    Save

18. Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016

    E. '. 't Hoen, Jacquelyn D. Veraldi, B. Toebes, H. Hogerzeil

    2018Bulletin of the World Health Organization55 citations Open access

    Semantic Scholar

    Save

19. Instability of (methyl)ergometrine in tropical climates: an overview.

    H. Hogerzeil, G. Walker

    1996European Journal of Obstetrics, Gynecology, and Reproductive Biology52 citations

    Semantic Scholar

    Save

20. Stability of essential drugs in Sudan

    H. Hogerzeil, M. J. de Goeje, Abu-Reid

    199145 citations

    Semantic Scholar

    Save

21. Potency of ergometrine in tropical countries.

    G. Walker, H. Hogerzeil, U. Hillgren

    198842 citations

    Semantic Scholar

    Save

22. The quality and stability of essential drugs in rural Zimbabwe: controlled longitudinal study

    H. Nazerali, H. Hogerzeil

    1998British medical journal41 citations Open access

    Semantic Scholar

    Save

23. Essential medicines are still essential.

    A. Gray, V. Wirtz, E. '. 't Hoen, M. Reich +1 more

    2015The Lancet34 citations

    Semantic Scholar

    Save

24. The right to health as the basis for universal health coverage: A cross-national analysis of national medicines policies of 71 countries

    S. K. Perehudoff, Nikita V. Alexandrov, H. Hogerzeil

    2019PLoS ONE31 citations Open access

    Semantic Scholar

    Save

25. Big Pharma and social responsibility--the Access to Medicine Index.

    H. Hogerzeil

    2013New England Journal of Medicine30 citations

    Semantic Scholar

    Save

26. Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country

    Daniela Moye-Holz, J. V. van Dijk, S. Reijneveld, H. Hogerzeil

    2017Globalization and Health29 citations Open access

    Semantic Scholar

    Save

27. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico

    Daniela Moye-Holz, M. Ewen, A. Dreser, S. Bautista-Arredondo +4 more

    2019BMC Health Services Research28 citations Open access

    Semantic Scholar

    Save

28. Legislating for universal access to medicines: a rights-based cross-national comparison of UHC laws in 16 countries

    S. Katrina Perehudoff, Nikita V. Alexandrov, H. Hogerzeil

    2019Health Policy and Planning26 citations Open access

    Semantic Scholar

    Save

29. The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country-The Case of Mexico.

    Daniela Moye-Holz, J. V. van Dijk, S. Reijneveld, H. Hogerzeil

    2019Value in Health Regional Issues26 citations Open access

    Semantic Scholar

    Save

30. A review of promoting access to medicines in China - problems and recommendations

    Jing Sun, C. J. Hu, M. Stuntz, H. Hogerzeil +1 more

    2018BMC Health Services Research26 citations Open access

    Semantic Scholar

    Save

31. Access to essential medicines in 195 countries: A human rights approach to sustainable development

    S. Katrina Perehudoff, Nikita V. Alexandrov, H. Hogerzeil

    2018Global Public Health24 citations

    Semantic Scholar

    Save

32. Management of type 1 diabetes in low‐ and middle‐income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania

    A. Abdraimova, S. Besançon, Jill Portocarrero, K. Ramaiya +14 more

    2022Diabetic Medicine23 citations Open access

    Semantic Scholar

    Save

33. Essential Medicines in National Constitutions

    S. Katrina Perehudoff, B. Toebes, H. Hogerzeil

    2016Health and Human Rights: An International Journal17 citations

    Semantic Scholar

    Save

34. A human rights-based approach to the reimbursement of expensive medicines

    K. Perehudoff, B. Toebes, H. Hogerzeil

    2016Bulletin of the World Health Organization16 citations Open access

    Semantic Scholar

    Save

35. Decision Criteria for Selecting Essential Medicines and their Connection to Guidelines: An Interpretive Descriptive Qualitative Interview Study.

    Thomas Piggott, L. Moja, E. Akl, J. Lavis +6 more

    2022Journal of Clinical Epidemiology15 citations Open access

    Semantic Scholar

    Save

36. A global accountability mechanism for access to essential medicines.

    Mariângela Simão, V. Wirtz, L. Al-ansary, S. Hill +6 more

    2018The Lancet15 citations

    Semantic Scholar

    Save

37. The importance of insulin donations for children in 43 low- and middle-income countries

    H. Hogerzeil, Sterre Recourt

    2019Journal of Public Health Policy14 citations Open access

    Semantic Scholar

    Save

38. The development of the noncommunicable diseases emergency health kit.

    S. Slama, Jonathan Lee, Mauricio Aragno, S. Laroche +1 more

    2018Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit14 citations Open access

    Semantic Scholar

    Save

39. Access to innovative cancer medicines in a middle-income country - the case of Mexico

    Daniela Moye-Holz, Rene Soria Saucedo, J. V. van Dijk, S. Reijneveld +1 more

    2018Journal of Pharmaceutical Policy and Practice14 citations Open access

    Semantic Scholar

    Save

40. Unsterile injections and emergence of human pathogens.

    Y. Hutin, P. Duclos, H. Hogerzeil, A. Ball +1 more

    2002The Lancet14 citations

    Semantic Scholar

    Save

41. Managing the third stage of labour. Oxytocin more stable in tropical climates.

    H. Hogerzeil, G. J. Walker, M. J. de Goeje

    1994British medical journal14 citations

    Semantic Scholar

    Save

42. Essential medicines for universal health coverage - Authors' reply.

    V. Wirtz, H. Hogerzeil, Andrew L Gray

    2017The Lancet13 citations Open access

    Semantic Scholar

    Save

43. Ensuring ethical drug promotion--whose responsibility?

    J. Quick, H. Hogerzeil, L. Rägo, V. Reggi +1 more

    2003The Lancet12 citations

    Semantic Scholar

    Save

44. Essential drugs for ration kits in developing countries.

    H. Haak, H. Hogerzeil

    1995Health Policy and Planning12 citations

    Semantic Scholar

    Save

45. Is the pharmaceutical industry improving with regard to access to essential medicines?

    H. Hogerzeil, J. Iyer, Lisa Urlings, Tara L Prasad +1 more

    2014Lancet Global Health9 citations Open access

    Semantic Scholar

    Save

46. Could the WHO Model List of Essential Medicines Do More for the Safe and Appropriate Use of Injections?

    Sophie M. D. Logez, Y. Hutin, K. Holloway, R. Gray +1 more

    2004Journal of clinical pharmacology8 citations

    Semantic Scholar

    Save

47. The New Emergency Health Kit

    H. Hogerzeil, J. Pinel

    1991Tropical doctor8 citations

    Semantic Scholar

    Save

48. Pharmaceutical industry, non-communicable diseases and partnerships: More questions than answers

    D. Beran, M. Ewen, F. Chappuis, Tim Reed +1 more

    2017Journal of Global Health6 citations

    Semantic Scholar

    Save

49. Health-sector reform in China and access to essential medicines.

    H. Hogerzeil, Jing Sun

    2013Lancet Global Health6 citations Open access

    Semantic Scholar

    Save

50. Global aspects of drug development.

    K. Hoppu, H. Hogerzeil

    2011Handbook of Experimental Pharmacology6 citations

    Semantic Scholar

    Save